Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04225104 · ClinicalTrials.gov registry record · NA
Yogic Breathing and IBS
A NA study, sponsored by Texas State University.
- Completed
- Registry status
- NA
- Development phase
- 14
- Enrollment target
NCT04225104: Completed NA study, sponsored by Texas State University.
NCT04225104 is a NA study that has completed, run by Texas State University. The registered enrollment target is 14 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04225104, a NA study, has completed, sponsored by Texas State University.
- COMPLETED
- Registry status
- NA
- Development phase
- 14 participants
- Enrollment target
Study Summary
Adults with irritable bowel syndrome (IBS) are being randomized to a yogic breathing or control condition. Participants randomized to the yogic breathing group will be asked to complete a 2-minute yogic breathing video 5 to 7 days per week at home for 4 weeks and control group participants will be asked to maintain their current activities. Participants in this group will be given access to the yogic breathing video at the end of the 4-week control period. IBS symptoms and autonomic and vascular function will be assessed at baseline and at the end of week 4 in both groups.
Primary Outcome
IBS-Symptom Severity Scale will be administered.
Interventions
- BEHAVIORAL Yogic breathing intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 14 participants |
| Start Date | 2019-04-15 |
| Est. Completion | 2020-03-01 |
| Phase | NA |
What the finished NCT04225104 record still lists
NCT04225104 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 14 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 1 intervention - of which Yogic breathing intervention is the first listed.
NCT04225104 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04225104 about?
NCT04225104 is a clinical study titled "Yogic Breathing and IBS". Adults with irritable bowel syndrome (IBS) are being randomized to a yogic breathing or control condition. Participants randomized to the yogic breathing group will be asked to complete a 2-minute yogic breathing video 5 to 7 days per week at home for 4 weeks and control group participants will be a...
What is the current status of trial NCT04225104?
This trial is currently completed. It is a NA study. The enrollment target is 14 participants. The study started on 2019-04-15. Estimated completion is 2020-03-01.
What interventions are being tested in trial NCT04225104?
The interventions under investigation include: Yogic breathing intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT04225104?
This trial is sponsored by Texas State University, which has 10 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04225104's enrollment target sits among peer trials
14 1909th of 2000 higher than 90 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02523092 · 14 participants · Phase 4
Use of CXCL9 as a Biomarker of Acthar Efficacy
- NCT04263285 · 14 participants · NA
Treatment of Depression Post-SCI
- NCT04743271 · 14 participants · NA
Food and Circadian Timing
- NCT05065671 · 14 participants · Phase 1
Microbiome Derived Metabolism and Pharmacokinetics
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT06358040 · started 2026-10 · NA
Opioid Dispenser for Microdiscectomy/Laminectomy